Memory Pharmaceuticals' P2P Acquisition

Memory Pharmaceuticals raised a round of funding on November 26, 2008. Investors include Roche Holding.

Memory Pharmaceuticals Corp., a publicly traded biopharmaceutical company, focuses on developing drugs for the treatment of CNS disorders such as Alzheimer's disease, schizophrenia, depression and bip…

Articles about Memory Pharmaceuticals' P2P Acquisition: